An unexpected tail of VEGF and PlGF in pre-eclampsia

Biochemical Society Transactions

Volumn 39, Issue 6, 2011, Pages 1576-1582

  Bates, David O ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Placental growth factor (PLGF); Pre eclampsia; Vascular endothelial growth factor (VEGF)

Indexed keywords

CADHERIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN; PADGEM PROTEIN; PLACENTAL GROWTH FACTOR; PROSTACYCLIN; SUPEROXIDE; TYROSINE KINASE RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ALTERNATIVE RNA SPLICING; BINDING AFFINITY; CONFERENCE PAPER; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; HUMAN; HYPOXIA; NONHUMAN; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UPREGULATION; VASODILATATION;

ANIMALS; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 81855226997     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20110671     Document Type: Conference Paper

References (84)

1. Roberts, J.M., Taylor, R.N., Musci, T.J., Rodgers, G.M., Hubel, C.A. and McLaughlin, M.K. (1989) Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 161, 1200-1204 (Pubitemid 20007682)
2. Anon (1998) Why Mothers Die: Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1994-1996, The Stationery Office, London
3. Anon (2000) CESDI: Confidential Enquiries into Stillbirths and Deaths in Infancy, The Stationery Office, London
4. Foidart, J.M., Schaaps, J.P., Chantraine, F., Munaut, C. and Lorquet, S. (2009) Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia: a step forward but not the definitive answer. J. Reprod. Immunol. 82, 106-111
5. Neal, C.R., Hunter, A.J., Harper, S.J., Soothill, P.W. and Bates, D.O. (2004) Plasma from women with severe pre-eclampsia increases microvascular permeability in an animal model in vivo. Clin. Sci. 107, 399-405 (Pubitemid 39389307)
6. Brockelsby, J., Hayman, R., Ahmed, A., Warren, A., Johnson, I. and Baker, P. (1999) VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia. Lab. Invest. 79, 1101-1111 (Pubitemid 29444540)
7. Brockelsby, J.C., Anthony, F.W., Johnson, I.R. and Baker, P.N. (2000) The effects of vascular endothelial growth factor on endothelial cells: a potential role in preeclampsia. Am. J. Obstet. Gynecol. 182, 176-183 (Pubitemid 30074389)
8. Levine, R.J., Maynard, S.E., Qian, C., Lim, K.H., England, L.J., Yu, K.F., Schisterman, E.F., Thadhani, R., Sachs, B.P., Epstein, F.H. et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672-683 (Pubitemid 38364626)
9. Chung, J.Y., Song, Y., Wang, Y., Magness, R.R. and Zheng, J. (2004) Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies. J. Clin. Endocrinol. Metab. 89, 2484-2490 (Pubitemid 38619893)
10. Sgambati, E., Marini, M., Zappoli Thyrion, G.D., Parretti, E., Mello, G., Orlando, C., Simi, L., Tricarico, C., Gheri, G. and Brizzi, E. (2004) VEGF expression in the placenta from pregnancies complicated by hypertensive disorders. BJOG 111, 564-570 (Pubitemid 38746240)
11. Senger, D.R., Galli, S.J., Dvorak, A.M., Perruzzi, C.A., Harvey, V.S. and Dvorak, H.F. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985
12. Ferrara, N. (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25, 581-611
13. Ferrara, N. and Keyt, B. (1997) Vascular endothelial growth factor: basic biology and clinical implications. EXS 79, 209-232
14. Wheeler, T., Elcock, C.L. and Anthony, F.W. (1995) Angiogenesis and the placental environment. Placenta 16, 289-296
15. 165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res. 62, 4123-4131
16. Reuvekamp, A., Velsing-Aarts, F.V., Poulina, I.E., Capello, J.J. and Duits, A.J. (1999) Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br. J. Obstet. Gynaecol. 106, 1019-1022 (Pubitemid 29457082)
17. Munaut, C., Lorquet, S., Pequeux, C., Blacher, S., Berndt, S., Frankenne, F. and Foidart, J.M. (2008) Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast. Hum. Reprod. 23, 1407-1415 (Pubitemid 351770590)
18. Bates, D.O. and Harper, S.J. (2002) Regulation of vascular permeability by vascular endothelial growth factors. Vasc. Pharmacol. 39, 225-237 (Pubitemid 37490748)
19. 165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 64, 7822-7835
20. 165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity. Cancer Res. 68, 4683-4692
21. Cebe Suarez, S., Pieren, M., Cariolato, L., Arn, S., Hoffmann, U., Bogucki, A., Manlius, C., Wood, J. and Ballmer-Hofer, K. (2006) A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2. Cell. Mol. Life Sci. 63, 2067-2077 (Pubitemid 44359746)
22. 165b transiently increases hydraulic conductivity, probably through VEGF receptor 1 in vivo. J. Physiol. 572, 243-257
23. Hillman, N.J., Whittles, C.E., Pocock, T.M., Williams, B. and Bates, D.O. (2001) Differential effects of vascular endothelial growth factor-C and placental growth factor-1 on the hydraulic conductivity of frog mesenteric capillaries. J. Vasc. Res. 38, 176-186 (Pubitemid 32337219)
24. Kendall, R.L. and Thomas, K.A. (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. U.S.A. 90, 10705-10709 (Pubitemid 23347111)
25. Albuquerque, R.J., Hayashi, T., Cho, W.G., Kleinman, M.E., Dridi, S., Takeda, A., Baffi, J.Z., Yamada, K., Kaneko, H., Green, M.G. et al. (2009) Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat. Med. 15, 1023-1030
26. Baker, P.N., Krasnow, J., Roberts, J.M. and Yeo, K.T. (1995) Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet. Gynecol. 86, 815-821
27. Sharkey, A.M., Cooper, J.C., Balmforth, J.R., McLaren, J., Clark, D.E., Charnock-Jones, D.S., Morris, N.H. and Smith, S.K. (1996) Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur. J. Clin. Invest. 26, 1182-1185
28. Tranquilli, A.L., Bezzeccheri, V., Giannubilo, S.R., Scagnoli, C., Mazzanti, L. and Garzetti, G.G. (2004) Amniotic vascular endothelial growth factor (VEGF) and nitric oxide (NO) in women with subsequent preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 113, 17-20 (Pubitemid 38281188)
29. Galazios, G., Papazoglou, D., Giagloglou, K., Vassaras, G., Koutlaki, N. and Maltezos, E. (2004) Umbilical cord serum vascular endothelial growth factor (VEGF) levels in normal pregnancies and in pregnancies complicated by preterm delivery or pre-eclampsia. Int. J. Gynaecol. Obstet. 85, 6-11 (Pubitemid 38438269)
30. Roes, E.M., Steegers, E.A., Thomas, C.M., Geurts-Moespot, A., Raijmakers, M.T., Peters, W.H. and Sweep, C.G. (2004) High levels of urinary vascular endothelial growth factor in women with severe preeclampsia. Int. J. Biol. Markers 19, 72-75 (Pubitemid 38515015)
31. Livingston, J.C., Chin, R., Haddad, B., McKinney, E.T., Ahokas, R. and Sibai, B.M. (2000) Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am. J. Obstet. Gynecol. 183, 1554-1557 (Pubitemid 32061224)
32. Lyall, F., Greer, I.A., Boswell, F. and Fleming, R. (1997) Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br. J. Obstet. Gynaecol. 104, 223-228 (Pubitemid 27065149)
33. Lyall, F., Young, A., Boswell, F., Kingdom, J. and Greer, I.A. (1997) Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 18, 269-276 (Pubitemid 27214230)
34. Anthony, F.W., Evans, P.W., Wheeler, T. and Wood, P.J. (1997) Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann. Clin. Biochem. 34, 276-280 (Pubitemid 27236931)
35. Maynard, S.E., Min, J.Y., Merchan, J., Lim, K.H., Li, J., Mondal, S., Libermann, T.A., Morgan, J.P., Sellke, F.W., Stillman, I.E. et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649-658
36. Jelkmann, W. (2001) Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin. Chem. 47, 617-623
37. 165b splice variant in pre-eclampsia. BJOG 118, 1253-1261
38. Hunter, A., Aitkenhead, M., Caldwell, C., McCracken, G., Wilson, D. and McClure, N. (2000) Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension 36, 965-969
39. Cooper, J.C., Sharkey, A.M., Charnock-Jones, D.S., Palmer, C.R. and Smith, S.K. (1996) VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br. J. Obstet. Gynaecol. 103, 1191-1196 (Pubitemid 26402883)
40. 165b in maternal plasma is a first trimester predictive marker for pre-eclampsia. Clin. Sci. 116, 265-272
41. Masuyama, H., Suwaki, N., Nakatsukasa, H., Masumoto, A., Tateishi, Y. and Hiramatrsu, Y. (2006) Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis. Am. J. Obstet. Gynecol. 194, 551-556 (Pubitemid 43183715)
42. Tsatsaris, V., Goffin, F., Munaut, C., Brichant, J.F., Pignon, M.R., Noel, A., Schaaps, J.P., Cabrol, D., Frankenne, F. and Foidart, J.M. (2003) Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J. Clin. Endocrinol. Metab. 88, 5555-5563 (Pubitemid 37452769)
43. Koga, K., Osuga, Y., Yoshino, O., Hirota, Y., Ruimeng, X., Hirata, T., Takeda, S., Yano, T., Tsutsumi, O. and Taketani, Y. (2003) Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J. Clin. Endocrinol. Metab. 88, 2348-2351 (Pubitemid 36549917)
44. McKeeman, G.C., Ardill, J.E., Caldwell, C.M., Hunter, A.J. and McClure, N. (2004) Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am. J. Obstet. Gynecol. 191, 1240-1246 (Pubitemid 39421577)
45. 2-macroglobulin and the binding is inhibited by heparin. J. Biol. Chem. 268, 7685-7691
46. 2-macroglobulin/growth factor binding. J. Biol. Chem. 275, 26806-26811
47. Maglione, D., Guerriero, V., Viglietto, G., Ferraro, M.G., Aprelikova, O., Alitalo, K., Del Vecchio, S., Lei, K.J., Chou, J.Y. and Persico, M.G. (1993) Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene 8, 925-931 (Pubitemid 23087424)
48. Cao, Y., Ji, W.R., Qi, P. and Rosin, A. (1997) Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. Biochem. Biophys. Res. Commun. 235, 493-498 (Pubitemid 27326507)
49. Yang, W., Ahn, H., Hinrichs, M., Torry, R.J. and Torry, D.S. (2003) Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human trophoblast and endothelial cells. J. Reprod. Immunol. 60, 53-60 (Pubitemid 37272295)
50. Madazli, R., Aydin, S., Uludag, S., Vildan, O. and Tolun, N. (2003) Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet. Gynecol. Scand. 82, 797-802 (Pubitemid 37082907)
51. Bersinger, N.A. and Odegard, R.A. (2005) Serum levels of macrophage colony stimulating, vascular endothelial, and placenta growth factor in relation to later clinical onset of pre-eclampsia and a small-for-gestational age birth. Am. J. Reprod. Immunol. 54, 77-83 (Pubitemid 41087070)
52. Thadhani, R., Mutter, W.P., Wolf, M., Levine, R.J., Taylor, R.N., Sukhatme, V.P., Ecker, J. and Karumanchi, S.A. (2004) First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J. Clin. Endocrinol. Metab. 89, 770-775 (Pubitemid 38269892)
53. Roberts, J.M., Taylor, R.N. and Goldfien, A. (1991) Endothelial cell activation as a pathogenetic factor in preeclampsia. Semin. Perinatol. 15, 86-93
54. Taylor, R.N., Casal, D.C., Jones, L.A., Varma, M., Martin, Jr, J.N. and Roberts, J.M. (1991) Selective effects of preeclamptic sera on human endothelial cell procoagulant protein expression. Am. J. Obstet. Gynecol. 165, 1705-1710
55. Taylor, R.N., Musci, T.J., Rodgers, G.M. and Roberts, J.M. (1991) Preeclamptic sera stimulate increased platelet-derived growth factor mRNA and protein expression by cultured human endothelial cells. Am. J. Reprod. Immunol. 25, 105-108
56. Brockelsby, J., Hayman, R., Ahmed, A., Warren, A., Johnson, I. and Baker, P. (1999) VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia. Lab. Invest. 79, 1101-1111 (Pubitemid 29444540)
57. Sankaralingam, S., Xu, H. and Davidge, S.T. (2010) Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia. Cardiovasc. Res. 85, 194-203
58. Kauma, S., Takacs, P., Scordalakes, C., Walsh, S., Green, K. and Peng, T. (2002) Increased endothelial monocyte chemoattractant protein-1 and interleukin-8 in preeclampsia. Obstet. Gynecol. 100, 706-714 (Pubitemid 35300027)
59. Takacs, P., Green, K.L., Nikaeo, A. and Kauma, S.W. (2003) Increased vascular endothelial cell production of interleukin-6 in severe preeclampsia. Am. J. Obstet. Gynecol. 188, 740-744 (Pubitemid 36332443)
60. Zhang, Y., Gu, Y., Lewis, D.F. and Wang, Y. (2006) Reduced cellular glutathione reductase activity and increased adhesion molecule expression in endothelial cells cultured with maternal plasma from women with preeclampsia. J. Soc. Gynecol. Invest. 13, 412-417 (Pubitemid 46059283)
61. Rowe, J., Campbell, S. and Gallery, E.D. (2001) Plasma from preeclamptic women stimulates decidual endothelial cell growth and prostacyclin but not nitric oxide production: close correlation of prostacyclin and thromboxane production. J. Soc. Gynecol. Invest. 8, 32-38 (Pubitemid 32157080)
62. Groten, T., Kreienberg, R., Fialka, I., Huber, L. and Wedlich, D. (2000) Altered subcellular distribution of cadherin-5 in endothelial cells caused by the serum of pre-eclamptic patients. Mol. Hum. Reprod. 6, 1027-1032
63. Ido, Y., Chang, K.C., Lejeune, W.S., Bjercke, R.J., Reiser, K.M., Williamson, J.R. and Tilton, R.G. (2001) Vascular dysfunction induced by AGE is mediated by VEGF via mechanisms involving reactive oxygen species, guanylate cyclase, and protein kinase C. Microcirculation 8, 251-263 (Pubitemid 33598131)
64. Hippenstiel, S., Krull, M., Ikemann, A., Risau, W., Clauss, M. and Suttorp, N. (1998) VEGF induces hyperpermeability by a direct action on endothelial cells. Am. J. Physiol. 274, L678-L684
65. Kevil, C.G., Payne, D.K., Mire, E. and Alexander, J.S. (1998) Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J. Biol. Chem. 273, 15099-15103 (Pubitemid 28272806)
66. Marumo, T., Schini-Kerth, V.B. and Busse, R. (1999) Vascular endothelial growth factor activates nuclear factor-κB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 48, 1131-1137 (Pubitemid 29226362)
67. Tezono, K., Sarker, K.P., Kikuchi, H., Nasu, M., Kitajima, I. and Maruyama, I. (2001) Bioactivity of the vascular endothelial growth factor trapped in fibrin clots: production of IL-6 and IL-8 in monocytes by fibrin clots. Haemostasis 31, 71-79 (Pubitemid 34701653)
68. Kim, I., Moon, S.O., Kim, S.H., Kim, H.J., Koh, Y.S. and Koh, G.Y. (2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-κB activation in endothelial cells. J. Biol. Chem. 276, 7614-7620
69. Wheeler-Jones, C., Abu-Ghazaleh, R., Cospedal, R., Houliston, R.A., Martin, J. and Zachary, I. (1997) Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Lett. 420, 28-32 (Pubitemid 28037194)
70. Bates, D.O. and Curry, F.E. (1996) Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. Am. J. Physiol. Heart Circ. Physiol. 271, H2520-H2528
71. Whittles, C.E., Pocock, T.M., Wedge, S.R., Kendrew, J., Hennequin, L.F., Harper, S.J. and Bates, D.O. (2002) ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity. Microcirculation 9, 513-522 (Pubitemid 135684861)
72. 165b is cytoprotective and antiangiogenic in the retina. Invest. Ophthalmol. Visual Sci. 51, 4273-4281
73. Bates, D.O., Hillman, N.J., Williams, B., Neal, C.R. and Pocock, T.M. (2002) Regulation of microvascular permeability by vascular endothelial growth factors. J. Anat. 200, 581-597 (Pubitemid 34823050)
74. Luttun, A., Brusselmans, K., Fukao, H., Tjwa, M., Ueshima, S., Herbert, J.M., Matsuo, O., Collen, D., Carmeliet, P. and Moons, L. (2002) Loss of placental growth factor protects mice against vascular permeability in pathological conditions. Biochem. Biophys. Res. Commun. 295, 428-434 (Pubitemid 34785852)
75. Osol, G., Celia, G., Gokina, N., Barron, C., Chien, E., Mandala, M., Luksha, L. and Kublickiene, K. (2008) Placental growth factor is a potent vasodilator of rat and human resistance arteries. Am. J. Physiol. Heart Circ. 294, H1381-H1387 (Pubitemid 351468737)
76. Ferrara, N. (1999) Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med. 77, 527-543
77. Barleon, B., Totzke, F., Herzog, C., Blanke, S., Kremmer, E., Siemeister, G., Marmé, D. and Martiny-Baron, G. (1997) Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT- 1. J. Biol. Chem. 272, 10382-10388
78. Sharkey, A.M., Cooper, J.C., Balmforth, J.R., McLaren, J., Clark, D.E., Charnock-Jones, D.S., Morris, N.H. and Smith, S.K. (1996) Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur. J. Clin. Invest. 26, 1182-1185
79. Kupferminc, M.J., Daniel, Y., Englender, T., Baram, A., Many, A., Jaffa, A.J., Gull, I. and Lessing, J.B. (1997) Vascular endothelial growth factor is increased in patients with preeclampsia. Am. J. Reprod. Immunol. 38, 302-306 (Pubitemid 27427425)
80. Hunter, A., Aitkenhead, M., Caldwell, C., McCracken, G., Wilson, D. and McClure, N. (2000) Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension 36, 965-969
81. Bosio, P.M., Wheeler, T., Anthony, F., Conroy, R., O'Herlihy, C. and McKenna, P. (2001) Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. Am. J. Obstet. Gynecol. 184, 146-152 (Pubitemid 32141657)
82. Taylor, R.N., Grimwood, J., Taylor, R.S., McMaster, M.T., Fisher, S.J. and North, R.A. (2003) Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am. J. Obstet. Gynecol. 188, 177-182 (Pubitemid 36135616)
83. Muy-Rivera, M., Vadachkoria, S., Woelk, G.B., Qiu, C., Mahomed, K. and Williams, M.A. (2005) Maternal plasma VEGF, sVEGF-R1, and PlGF concentrations in preeclamptic and normotensive pregnant Zimbabwean women. Physiol. Res. 54, 611-622 (Pubitemid 43161727)
84. Staff, A.C., Braekke, K., Harsem, N.K., Lyberg, T. and Holthe, M.R. (2005) Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 122, 33-39 (Pubitemid 41265677)